Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Suspended × icotinib × Clear all

Phase

Status

Unknown 7 Completed 2 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

icotinib 1 abarelix 1 Watchful Waiting 1 Testosterone Propionate 1 Testosterone 1 Specimen Handling 1 Prednisone 1 Oxycodone 1 Observation 1 Morphine 1 Magnetic Resonance Spectroscopy 1 Fentanyl 1 Erlotinib Hydrochloride 1 Clinical Protocols 1 Buprenorphine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01720901 2015-05-22

Increased Dose of Icotinib in Advanced None Small Cell Lung Cancer Patients After Routine Gefitinib Therapy

Betta Pharmaceuticals Co., Ltd.

Phase 4 Suspended

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡